Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
Dora D, Revisnyei P, Pasic A, Galffy G, Dulka E, Mihucz A, Rosk? B, Szincsak S, Iliuk A, Weiss GJ, Lohinai Z. Host and bacterial urine proteomics might predict treatment outcomes for immunotherapy in advanced non-small cell lung cancer patients. Front Immunol. 2025; 16:1543817.
-
Heilbrun EE, Tseitline D, Wasserman H, Kirshenbaum A, Cohen Y, Gordan R, Adar S. The epigenetic landscape shapes smoking-induced mutagenesis by modulating DNA damage susceptibility and repair efficiency. Nucleic Acids Res. 2025 Feb 08; 53(4).
-
Heilbrun EE, Tseitline D, Wasserman H, Kirshenbaum A, Cohen Y, Gordan R, Adar S. The epigenetic landscape shapes smoking-induced mutagenesis by modulating DNA damage susceptibility and repair efficiency. Nucleic Acids Res. 2025 Feb 08; 53(4).
-
D'Addario AE, Fukunaga MI, King AM, Singh S, Mazor KM, Fisher KA. Lung cancer screening: What do physicians say to reluctant patients and what do patients want them to say? Patient Educ Couns. 2025 May; 134:108698.
-
DiGirolamo GJ, Sorcini F, Zaniewski Z, Kruskal JB, Rosen MP. Non-Conscious Detection of "Missed" Lung Nodules by Radiologists: Expanding the Boundaries of Successful Processing During the Visual Assessment of Chest CT Scans. Radiology. 2025 Feb; 314(2):e232996.
-
Peker A, Sinha A, King RM, Minnaard J, Sterren WV, Bydlon T, Bankier AA, Gounis MJ. A Novel Method for the Generation of Realistic Lung Nodules Visualized Under X-Ray Imaging. Tomography. 2024 Dec 05; 10(12):1959-1969.
-
Nielsen N, Ballinger Z, Mu?oz Villarreal B, Kovell L, Ito Fukunaga M, Casta?eda-Avila M. Estimating the Impact of Asthma and COPD on Lung Cancer Screening in the USA. Lung. 2024 Nov 27; 203(1):2.
-
Osataphan S, Awidi M, Jan YJ, Gunturu K, Sundararaman S, Viray H, Frankenberger E, Mariano M, O'Loughlin L, Piper-Vallillo A, Stafford K, Kolnick A, Ghazalah H, Sehgal K, Patti ME, Costa D, Lam P, Rangachari D. Association between higher glucose levels and reduced survival in patients with non-small cell lung cancer treated with immune checkpoint inhibitors. Lung Cancer. 2024 Dec; 198:108023.
-
Babu S, Horowitz M, Delgado-Coka LA, Roa-Pe?a L, Akalin A, Escobar-Hoyos LF, Shroyer KR. Keratin 17 and A2ML1 are negative prognostic biomarkers in non-small cell lung cancer. Pathol Res Pract. 2024 Nov; 263:155643.
-
Karpinski P, Mendez-Pena JE, Wu CL, Akalin A, Cornejo KM, Hung YP, Hoang MP. POU4F3 Is a Sensitive and Specific Marker of Merkel Cell Carcinoma. Mod Pathol. 2025 Jan; 38(1):100627.